The two-way tug-of-war between solid operational momentum and headline-driven political risk has taken a sharp turn in favour of the bears. The Amsterdam-listed defence group CSG saw its shares shed nearly 17% over the past five trading sessions, closing Friday at €15.05. At the heart of the sell-off is an unconfirmed Reuters report that the company has approached the German and French owners of tankmaker KNDS — the joint venture between Krauss-Maffei Wegmann and Nexter — about buying a stake. But the path is strewn with obstacles: Berlin is reportedly angling for a 30–40% holding in KNDS as an alternative, while an initial public offering valuing the target at between €15bn and €20bn is tentatively scheduled for early July. With no official confirmation of terms or timelines, every fresh whisper on the KNDS front is whipsawing the stock like a political counter.
The contrast with CSG’s underlying business could hardly be starker. First-quarter revenue climbed 13.8% to €1.544bn, operating EBIT reached €372m (a margin of 24.1%) and net profit surged 83% to €299m. The order book hit a record €17bn, backed by a further €27bn in advanced negotiations. On the production side, CSG fired up a new artillery munitions line in Ukraine on 1 June, adding 100,000 units of 155mm shells and 50,000 of 105mm shells per year. A Slovak long-range munitions line is already running at full capacity of 70,000 units annually, and the group targets a total heavy-calibre output of 850,000 units by end-2026. Meanwhile, CSG has deepened its grip on the supply chain: through subsidiary Staluna Trade it now controls 9.9% of voting rights in German speciality chemicals maker Alzchem — a key source of nitroguanidine for propellants — and via total-return swaps it holds an additional 10.2% economic exposure.
Technicals paint a picture of extreme stress. The relative strength index sits at 31.8, signalling deep oversold territory, while the annualised 30-day volatility of almost 77% has been more typical of a speculative tech stock than a defence industrial name. From the January 52-week high of €36.05, the shares have now lost more than 58%; the distance to the May trough has narrowed to roughly 10%. All ten analysts covering the company rate it a buy, with a consensus price target of €32.05 and a bull case of €42. However, Berenberg recently trimmed its estimates and price target, citing uneven segment performance in the first quarter.
Should investors sell immediately? Or is it worth buying CSG?
On the non-military side, CSG’s Tatra Trucks unit used the Interschutz trade fair in Hannover to showcase four firefighting vehicles built on the Tatra Force chassis, alongside partners such as Rosenbauer and Excalibur Army. No new major orders or revenue guidance were announced, meaning the event failed to provide a catalyst. Broader sector headwinds also play a part: the European aerospace and defence index is down 1.2% year-to-date, while the Stoxx 600 has gained 4.8%, signalling that market euphoria over rising defence budgets is giving way to stock-picking scrutiny.
The next fundamental checkpoint comes on 7 August, when CSG releases its half-year results. A silent period begins on 7 July. Until then, the outcome of the KNDS poker game — and whether Berlin ultimately backs an IPO or a state entry — will likely determine if the €15 mark holds as a floor or the decline deepens. Given the yawning gap between operational strength and market sentiment, the stock presents a classic test of whether political noise can outweigh the numbers for much longer.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from June 7 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 7.
CSG: Buy or sell? Read more here...
